Announcements Trials
Browse Landscape

Phase

Phase 2 12Phase 3 6Phase 1 2Phase 1/2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 10Sarcoma 3Unspecified Adult Solid Tumor, Protocol Specific 2Neoplasms 2Inflammatory Breast Neoplasms 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Prostatic Neoplasms 1Patients With Advanced or Metastatic Solid Tumors 1Ovarian Neoplasms 1Osteosarcoma 1Neutropenia 1Liver Neoplasms 1Gallbladder Neoplasms 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms, Male 1Bile Duct Neoplasms 1

Interventions

Trastuzumab 3Cyclophosphamide 3pembrolizumab 2Radiotherapy 2Filgrastim 2Epirubicin 2Carboplatin 2tipifarnib 1pegfilgrastim 1olaparib 1aldesleukin 1Thiotepa 1Tamoxifen 1Semaxinib 1Peripheral Blood Stem Cell Transplantation 1Interleukin-12 Subunit p35 1Interleukin-12 1Immunohistochemistry 1Fluorouracil 1Fluorescent Antibody Technique 1Flow Cytometry 1Doxorubicin 1Docetaxel 1Diathermy 1Capecitabine 1Biopsy 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Inflammatory Breast Neoplasms × Epirubicin × Clear all
NCT01880385 2013-06-19

Beva

Association Tunisienne de lutte Contre le Cancer

Phase 1 Unknown
30 enrolled
Breast

Inflammatory Breast Neoplasms

NCT00008034 2012-07-18

Combination Chemotherapy Before Surgery in Treating Women With Breast Cancer

European Organisation for Research and Treatment of Cancer - EORTC

Phase 1 Completed
15 enrolled
Breast

Breast Neoplasms, Inflammatory Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡